| Primary |
| Supplementation Therapy |
17.4% |
| Blood Pressure Abnormal |
13.0% |
| Hypertension |
8.7% |
| Vitamin Supplementation |
8.7% |
| Anticoagulant Therapy |
4.3% |
| Anxiety |
4.3% |
| Arthritis |
4.3% |
| Calcium Supplementation |
4.3% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Hypercholesterolaemia |
4.3% |
| Nutritional Support |
4.3% |
| Product Used For Unknown Indication |
4.3% |
| Prostatic Disorder |
4.3% |
| Relaxation Therapy |
4.3% |
| Sleep Disorder |
4.3% |
| Thyroid Disorder |
4.3% |
|
| Product Size Issue |
16.7% |
| Cystitis |
8.3% |
| Dyspnoea |
8.3% |
| Lethargy |
8.3% |
| Musculoskeletal Stiffness |
8.3% |
| Nausea |
8.3% |
| No Adverse Event |
8.3% |
| Overdose |
8.3% |
| Rash |
8.3% |
| Somnolence |
8.3% |
| Vocal Cord Disorder |
8.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.7% |
| Product Used For Unknown Indication |
17.8% |
| Hepatitis C |
17.2% |
| Nutritional Support |
5.9% |
| Vitamin Supplementation |
5.3% |
| Asthma |
4.7% |
| Hypertension |
3.6% |
| Diabetes Mellitus |
3.0% |
| Hyperlipidaemia |
3.0% |
| Mineral Supplementation |
2.4% |
| Blood Cholesterol Increased |
1.8% |
| Blood Pressure High |
1.8% |
| Bronchiectasis |
1.8% |
| High Cholesterol |
1.8% |
| Medical Diet |
1.8% |
| Non-small Cell Lung Cancer |
1.8% |
| Routine Health Maintenance |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Ankle Swelling |
1.2% |
| Gastric Disorder |
1.2% |
|
| White Blood Cell Count Decreased |
28.6% |
| Weight Decreased |
9.5% |
| Vomiting |
7.1% |
| Diarrhoea |
4.8% |
| Flushing |
4.8% |
| Hepatic Enzyme Increased |
4.8% |
| Loss Of Consciousness |
4.8% |
| Musculoskeletal Stiffness |
4.8% |
| Off Label Use |
4.8% |
| Anaemia |
2.4% |
| Blindness Transient |
2.4% |
| Blood Creatine Increased |
2.4% |
| Choking |
2.4% |
| Coeliac Disease |
2.4% |
| Constipation |
2.4% |
| Dizziness |
2.4% |
| Dry Throat |
2.4% |
| Hypersensitivity |
2.4% |
| Implant Site Infection |
2.4% |
| Incorrect Drug Administration Duration |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.0% |
| Drug Use For Unknown Indication |
18.3% |
| Hypertension |
7.5% |
| Osteoporosis |
5.6% |
| Rheumatoid Arthritis |
3.8% |
| Vitamin Supplementation |
3.7% |
| Blood Cholesterol Increased |
3.4% |
| Pain |
3.0% |
| Diabetes Mellitus |
2.6% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Prophylaxis |
2.3% |
| Atrial Fibrillation |
2.2% |
| Supplementation Therapy |
2.0% |
| Arthritis |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Depression |
1.7% |
| Cardiac Disorder |
1.6% |
| Blood Pressure |
1.4% |
| Asthma |
1.4% |
| Hepatitis C |
1.2% |
|
| Weight Decreased |
13.1% |
| Vomiting |
12.6% |
| Weight Increased |
8.0% |
| Nausea |
6.0% |
| Pain In Extremity |
4.6% |
| Pneumonia |
4.6% |
| Drug Ineffective |
4.4% |
| Flushing |
4.4% |
| Pain |
4.4% |
| Death |
4.2% |
| Pruritus |
4.1% |
| Urinary Tract Infection |
4.0% |
| Vision Blurred |
3.8% |
| Diarrhoea |
3.5% |
| Myalgia |
3.4% |
| Pyrexia |
3.4% |
| Dyspnoea |
3.0% |
| Rash |
3.0% |
| Fatigue |
2.9% |
| Product Quality Issue |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
63.2% |
| Joint Swelling |
10.5% |
| Blood Cholesterol Abnormal |
5.3% |
| Blood Cholesterol Increased |
5.3% |
| Blood Pressure Abnormal |
5.3% |
| Constipation |
5.3% |
| Hypertension |
5.3% |
|
| Drug Interaction |
33.3% |
| Loss Of Consciousness |
16.7% |
| Memory Impairment |
16.7% |
| Road Traffic Accident |
16.7% |
| Syncope |
16.7% |
|
